Meeting
2023 ASCO Annual Meeting
Core biopsy (bx) accuracy and safety of biopsy and preoperative immunotherapy in predicting histological subtype and nuclear grade in ECOG-ACRIN EA8143 perioperative nivolumab (nivo) versus observation in patients (pts) with renal cell carcinoma (RCC) undergoing nephrectomy.
Authors
Naomi B. Haas
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Naomi B. Haas , Se Eun Kim , David F. McDermott , Viraj A. Master , Sabina Signoretti , Mahmut Akgul , Nick Baniak , Elsa Li Ning Tapia , Matthew Palmer , Hamid Emamekhoo , Bradley C. Leibovich , Brian M. Shuch , Anil Kapoor , M. Dror Michaelson , Gennady Bratslavsky , Michael Anthony Carducci , Mohamad E. Allaf
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Clinical Trial Registration Number
NCT03055013
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4541)
DOI
10.1200/JCO.2023.41.16_suppl.4541
Abstract #
4541
Poster Bd #
33
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma.
First Author: Maria Isabel Carlo
Poster
2020 ASCO Virtual Scientific Program
PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).
First Author: Naomi B. Haas
Poster
2020 Genitourinary Cancers Symposium
PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).
First Author: Lauren Christine Harshman
Poster
2019 ASCO Annual Meeting
PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).
First Author: Lauren Christine Harshman